| Year |
Citation |
Score |
| 2024 |
Durante D, Bott R, Cooper L, Owen C, Morsheimer KM, Patten JJ, Zielinski C, Peet NP, Davey RA, Gaisina IN, Rong L, Moore TW. N-Substituted Pyrrole-Based Heterocycles as Broad-Spectrum Filoviral Entry Inhibitors. Journal of Medicinal Chemistry. 67: 13737-13764. PMID 39169825 DOI: 10.1021/acs.jmedchem.4c00527 |
0.341 |
|
| 2024 |
Chen Z, Cui Q, Ran Y, Achi JG, Chen Z, Rong L, Du R. A BSL-2 compliant mouse model of SARS-CoV-2 infection for efficient and convenient antiviral evaluation. Journal of Virology. e0050424. PMID 38899934 DOI: 10.1128/jvi.00504-24 |
0.303 |
|
| 2024 |
Caffrey M, Jayakumar N, Caffrey V, Anirudhan V, Rong L, Paprotny I. VLP-based model for the study of airborne viral pathogens. Microbiology Spectrum. 12: e0001324. PMID 38752752 DOI: 10.1128/spectrum.00013-24 |
0.309 |
|
| 2024 |
Li Z, Li B, Liu M, Chen Z, Li P, Du R, Su M, Anirudhan V, Achi JG, Tian J, Rong L, Cui Q. Development of a virus-based affinity ultrafiltration method for screening virus-surface-protein-targeted compounds from complex matrixes: Herbal medicines as a case study. Journal of Medical Virology. 96: e29517. PMID 38476091 DOI: 10.1002/jmv.29517 |
0.339 |
|
| 2024 |
Song T, Cooper L, Galván Achi J, Wang X, Dwivedy A, Rong L, Wang X. Polyvalent Nanobody Structure Designed for Boosting SARS-CoV-2 Inhibition. Journal of the American Chemical Society. 146: 5894-5900. PMID 38408177 DOI: 10.1021/jacs.3c11760 |
0.316 |
|
| 2024 |
Gaisina I, Li P, Du R, Cui Q, Dong M, Zhang C, Manicassamy B, Caffrey M, Moore T, Cooper L, Rong L. An orally active entry inhibitor of influenza A viruses protects mice and synergizes with oseltamivir and baloxavir marboxil. Science Advances. 10: eadk9004. PMID 38394202 DOI: 10.1126/sciadv.adk9004 |
0.678 |
|
| 2024 |
Caffrey M, Jayakumar N, Caffrey V, Anirudan V, Rong L, Paprotny I. VLP-Based Model for Study of Airborne Viral Pathogens. Biorxiv : the Preprint Server For Biology. PMID 38260552 DOI: 10.1101/2024.01.03.574055 |
0.311 |
|
| 2024 |
Liu M, Li Z, Cui Q, Yan B, Achi JG, Zhao Y, Rong L, Du R. Integrated serum pharmacochemistry and investigation of the anti-influenza A virus pneumonia effect of Qingjin Huatan decoction. Journal of Ethnopharmacology. 323: 117701. PMID 38185258 DOI: 10.1016/j.jep.2024.117701 |
0.323 |
|
| 2023 |
Li P, Ju H, Xing Y, Zhao F, Anirudhan V, Du R, Cui Q, Liu X, Rong L, Zhan P. Identification of the Imidazo[1,2-]pyrazine Derivative as a Potential Influenza Virus Nucleoprotein Inhibitor. Acs Pharmacology & Translational Science. 6: 1841-1850. PMID 38093833 DOI: 10.1021/acsptsci.3c00174 |
0.36 |
|
| 2023 |
Zhu M, Anirudhan V, Du R, Rong L, Cui Q. Influenza virus cell entry and targeted antiviral development. Journal of Medical Virology. 95: e29181. PMID 37930075 DOI: 10.1002/jmv.29181 |
0.4 |
|
| 2023 |
Liang CY, Huang I, Han J, Sownthirarajan B, Kulhankova K, Murray NB, Taherzadeh M, Archer-Hartmann S, Pepi L, Manivasagam S, Plung J, Sturtz M, Yu Y, Vogel OA, Kandasamy M, ... ... Rong L, et al. Avian influenza A viruses exhibit plasticity in sialylglycoconjugate receptor usage in human lung cells. Journal of Virology. e0090623. PMID 37843369 DOI: 10.1128/jvi.00906-23 |
0.653 |
|
| 2023 |
Dong M, Wang Y, Li P, Chen Z, Anirudhan V, Cui Q, Rong L, Du R. Allopregnanolone targets nucleoprotein as a novel influenza virus inhibitor. Virologica Sinica. PMID 37741571 DOI: 10.1016/j.virs.2023.09.003 |
0.381 |
|
| 2023 |
Li P, Ju H, Zhang Y, Achi JG, Kang D, Zou J, Du R, Cui Q, Liu X, Rong L, Zhan P. Discovery of ligustrazine and chalcone derivatives as novel viral nucleoprotein nuclear export inhibitors against influenza viruses. Journal of Medical Virology. 95: e28968. PMID 37489704 DOI: 10.1002/jmv.28968 |
0.373 |
|
| 2022 |
Zhang C, Zhang G, Zhang Y, Lin X, Zhao X, Cui Q, Rong L, Du R. Development of an HiBiT-tagged reporter H3N2 influenza A virus and its utility as an antiviral screening platform. Journal of Medical Virology. PMID 36424458 DOI: 10.1002/jmv.28345 |
0.388 |
|
| 2022 |
Alqarni S, Cooper L, Galvan Achi J, Bott R, Sali VK, Brown A, Santarsiero BD, Krunic A, Manicassamy B, Peet NP, Zhang P, Thatcher GRJ, Gaisina IN, Rong L, Moore TW. Synthesis, Optimization, and Structure-Activity Relationships of Imidazo[1,2-]pyrimidines as Inhibitors of Group 2 Influenza A Viruses. Journal of Medicinal Chemistry. PMID 36260129 DOI: 10.1021/acs.jmedchem.2c01329 |
0.705 |
|
| 2022 |
Zhao X, Lin X, Li P, Chen Z, Zhang C, Manicassamy B, Rong L, Cui Q, Du R. Expanding the tolerance of segmented Influenza A Virus genome using a balance compensation strategy. Plos Pathogens. 18: e1010756. PMID 35926068 DOI: 10.1371/journal.ppat.1010756 |
0.681 |
|
| 2022 |
Qing E, Li P, Cooper L, Schulz S, Jäck HM, Rong L, Perlman S, Gallagher T. Inter-domain communication in SARS-CoV-2 spike proteins controls protease-triggered cell entry. Cell Reports. 39: 110786. PMID 35477024 DOI: 10.1016/j.celrep.2022.110786 |
0.32 |
|
| 2022 |
Du R, Cui Q, Caffrey M, Rong L. Ebola Virus Entry Inhibitors. Advances in Experimental Medicine and Biology. 1366: 155-170. PMID 35412140 DOI: 10.1007/978-981-16-8702-0_10 |
0.329 |
|
| 2022 |
Cooper L, Galvan Achi J, Rong L. Comparative analyses of small molecule and antibody inhibition on glycoprotein-mediated entry of Měnglà virus with other filoviruses. Journal of Medical Virology. 94: 3263-3269. PMID 35332563 DOI: 10.1002/jmv.27739 |
0.399 |
|
| 2022 |
Tsang NY, Li WF, Varhegyi E, Rong L, Zhang HJ. Ebola Entry Inhibitors Discovered from . International Journal of Molecular Sciences. 23. PMID 35269770 DOI: 10.3390/ijms23052620 |
0.324 |
|
| 2021 |
Malicoat J, Manivasagam S, Zuñiga S, Sola I, McCabe D, Rong L, Perlman S, Enjuanes L, Manicassamy B. Development of a Single-cycle Infectious SARS-CoV-2 Virus Replicon Particle System for use in BSL2 Laboratories. Journal of Virology. JVI0183721. PMID 34851142 DOI: 10.1128/JVI.01837-21 |
0.694 |
|
| 2021 |
Chen Z, Cui Q, Caffrey M, Rong L, Du R. Small Molecule Inhibitors of Influenza Virus Entry. Pharmaceuticals (Basel, Switzerland). 14. PMID 34207368 DOI: 10.3390/ph14060587 |
0.344 |
|
| 2021 |
Sarute N, Cheng H, Yan Z, Salas-Briceno K, Richner J, Rong L, Ross SR. Signal-regulatory protein alpha is an anti-viral entry factor targeting viruses using endocytic pathways. Plos Pathogens. 17: e1009662. PMID 34097709 DOI: 10.1371/journal.ppat.1009662 |
0.42 |
|
| 2021 |
Amaya M, Cheng H, Borisevich V, Navaratnarajah CK, Cattaneo R, Cooper L, Moore TW, Gaisina IN, Geisbert TW, Rong L, Broder CC. A recombinant Cedar virus based high-throughput screening assay for henipavirus antiviral discovery. Antiviral Research. 105084. PMID 34077807 DOI: 10.1016/j.antiviral.2021.105084 |
0.35 |
|
| 2021 |
Du R, Cooper L, Chen Z, Lee H, Rong L, Cui Q. Discovery of chebulagic acid and punicalagin as novel allosteric inhibitors of SARS-CoV-2 3CL. Antiviral Research. 190: 105075. PMID 33872675 DOI: 10.1016/j.antiviral.2021.105075 |
0.342 |
|
| 2021 |
Shen Z, Ratia K, Cooper L, Kong D, Lee H, Kwon Y, Li Y, Alqarni S, Huang F, Dubrovskyi O, Rong L, Thatcher GR, Xiong R. Potent, Novel SARS-CoV-2 PLpro Inhibitors Block Viral Replication in Monkey and Human Cell Cultures. Biorxiv : the Preprint Server For Biology. PMID 33594371 DOI: 10.1101/2021.02.13.431008 |
0.314 |
|
| 2021 |
Du R, Cheng H, Cui Q, Peet NP, Gaisina IN, Rong L. Identification of a novel inhibitor targeting influenza A virus group 2 hemagglutinins. Antiviral Research. 105013. PMID 33428962 DOI: 10.1016/j.antiviral.2021.105013 |
0.38 |
|
| 2020 |
Kang Q, Wang Y, Cui Q, Gong L, Yang Y, Jiang H, Rong L, Rong R, Du R. Screening for Anti-Influenza Actives of Prefractionated Traditional Chinese Medicines. Evidence-Based Complementary and Alternative Medicine : Ecam. 2020: 4979850. PMID 33123207 DOI: 10.1155/2020/4979850 |
0.363 |
|
| 2020 |
Cooper L, Schafer A, Li Y, Cheng H, Medegan Fagla B, Shen Z, Nowar R, Dye K, Anantpadma M, Davey RA, Thatcher GR, Rong L, Xiong R. Screening and Reverse-Engineering of Estrogen Receptor Ligands as Potent Pan-Filovirus Inhibitors. Journal of Medicinal Chemistry. PMID 32886512 DOI: 10.1021/Acs.Jmedchem.0C01001 |
0.441 |
|
| 2020 |
Du R, Cui Q, Rong L. Flu Universal Vaccines: New Tricks on an Old Virus. Virologica Sinica. PMID 32870450 DOI: 10.1007/S12250-020-00283-6 |
0.354 |
|
| 2020 |
Li P, Du R, Chen Z, Wang Y, Zhan P, Liu X, Kang D, Chen Z, Zhao X, Wang L, Rong L, Cui Q. Punicalagin is a neuraminidase inhibitor of influenza viruses. Journal of Medical Virology. PMID 32827314 DOI: 10.1002/Jmv.26449 |
0.492 |
|
| 2020 |
Wang Y, Anirudhan V, Du R, Cui Q, Rong L. RNA-dependent RNA Polymerase of SARS-CoV-2 as a Therapeutic Target. Journal of Medical Virology. PMID 32633831 DOI: 10.1002/Jmv.26264 |
0.352 |
|
| 2020 |
Antanasijevic A, Durst MA, Cheng H, Gaisina IN, Perez JT, Manicassamy B, Rong L, Lavie A, Caffrey M. Structure of avian influenza hemagglutinin in complex with a small molecule entry inhibitor. Life Science Alliance. 3. PMID 32611549 DOI: 10.26508/lsa.202000724 |
0.669 |
|
| 2020 |
Liu X, Wu Y, Rong L. Conditionally Reprogrammed Human Normal Airway Epithelial Cells at ALI: A Physiological Model for Emerging Viruses. Virologica Sinica. PMID 32557270 DOI: 10.1007/S12250-020-00244-Z |
0.315 |
|
| 2020 |
Gaisina IN, Peet NP, Wong L, Schafer AM, Cheng H, Anantpadma M, Davey RA, Thatcher GR, Rong L. Discovery and Structural Optimization of 4-(Aminomethyl)benzamides as Potent Entry Inhibitors of Ebola and Marburg Virus Infections. Journal of Medicinal Chemistry. PMID 32490678 DOI: 10.1021/Acs.Jmedchem.0C00463 |
0.458 |
|
| 2020 |
Li P, Du R, Wang Y, Hou X, Wang L, Zhao X, Zhan P, Liu X, Rong L, Cui Q. Identification of Chebulinic Acid and Chebulagic Acid as Novel Influenza Viral Neuraminidase Inhibitors. Frontiers in Microbiology. 11: 182. PMID 32256457 DOI: 10.3389/Fmicb.2020.00182 |
0.482 |
|
| 2020 |
Hussein AFA, Cheng H, Tundup S, Antanasijevic A, Varhegyi E, Perez J, AbdulRahman EM, Elenany MG, Helal S, Caffrey M, Peet N, Manicassamy B, Rong L. Identification of entry inhibitors with 4-aminopiperidine scaffold targeting group 1 influenza A virus. Antiviral Research. 104782. PMID 32222293 DOI: 10.1016/J.Antiviral.2020.104782 |
0.747 |
|
| 2020 |
Gaisina IN, Peet N, Cheng H, Li P, Du R, Cui Q, Furlong K, Manicassamy B, Caffrey M, Thatcher GR, Rong L. Optimization of 4-aminopiperidines as inhibitors of influenza A viral entry that are synergistic with oseltamivir. Journal of Medicinal Chemistry. PMID 32069052 DOI: 10.1021/Acs.Jmedchem.9B01900 |
0.729 |
|
| 2020 |
Cui Q, Du R, Liu M, Rong L. Lignans and Their Derivatives from Plants as Antivirals. Molecules (Basel, Switzerland). 25. PMID 31906391 DOI: 10.3390/Molecules25010183 |
0.302 |
|
| 2019 |
Zhao X, Wang Y, Cui Q, Li P, Wang L, Chen Z, Rong L, Du R. A Parallel Phenotypic Versus Target-Based Screening Strategy for RNA-Dependent RNA Polymerase Inhibitors of the Influenza A Virus. Viruses. 11. PMID 31491939 DOI: 10.3390/V11090826 |
0.458 |
|
| 2019 |
Wang L, Cui Q, Zhao X, Li P, Wang Y, Rong L, Du R. Generation of a Reassortant Influenza A Subtype H3N2 Virus Expressing Luciferase. Viruses. 11. PMID 31330768 DOI: 10.3390/V11070665 |
0.473 |
|
| 2019 |
Du R, Cui Q, Rong L. Competitive Cooperation of Hemagglutinin and Neuraminidase during Influenza A Virus Entry. Viruses. 11. PMID 31137516 DOI: 10.3390/V11050458 |
0.495 |
|
| 2018 |
Zhao X, Wang L, Cui Q, Li P, Wang Y, Zhang Y, Yang Y, Rong L, Du R. A Mechanism Underlying Attenuation of Recombinant Influenza A Viruses Carrying Reporter Genes. Viruses. 10. PMID 30513620 DOI: 10.3390/V10120679 |
0.423 |
|
| 2018 |
Cui Q, Cheng H, Xiong R, Zhang G, Du R, Anantpadma M, Davey RA, Rong L. Identification of Diaryl-Quinoline Compounds as Entry Inhibitors of Ebola Virus. Viruses. 10. PMID 30513600 DOI: 10.3390/V10120678 |
0.413 |
|
| 2018 |
Schafer A, Cheng H, Xiong R, Soloveva V, Retterer C, Mo F, Bavari S, Thatcher G, Rong L. Repurposing potential of 1st generation H-specific antihistamines as anti-filovirus therapeutics. Antiviral Research. PMID 29981374 DOI: 10.1016/J.Antiviral.2018.07.003 |
0.369 |
|
| 2018 |
Li P, Cui Q, Wang L, Zhao X, Zhang Y, Manicassamy B, Yang Y, Rong L, Du R. A Simple and Robust Approach for Evaluation of Antivirals Using a Recombinant Influenza Virus Expressing Luciferase. Viruses. 10. PMID 29899269 DOI: 10.3390/V10060325 |
0.73 |
|
| 2018 |
Cui Q, Du R, Anantpadma M, Schafer A, Hou L, Tian J, Davey RA, Cheng H, Rong L. Identification of Ellagic Acid from Plant Rhodiola rosea L. as an Anti-Ebola Virus Entry Inhibitor. Viruses. 10. PMID 29584652 DOI: 10.3390/V10040152 |
0.493 |
|
| 2017 |
Schafer AM, Cheng H, Lee C, Du R, Han J, Perez J, Peet N, Manicassamy B, Rong L. Development of Potential Small Molecule Therapeutics for Treatment of Ebola Virus. Current Medicinal Chemistry. PMID 29032747 DOI: 10.2174/0929867324666171010141416 |
0.721 |
|
| 2017 |
Han J, Perez J, Schafer A, Cheng H, Peet N, Rong L, Manicassamy B. Influenza Virus: Small Molecule Therapeutics and Mechanisms of Antiviral. Current Medicinal Chemistry. PMID 28933281 DOI: 10.2174/0929867324666170920165926 |
0.712 |
|
| 2017 |
Zhang HJ, Rumschlag-Booms E, Guan YF, Wang DY, Liu KL, Li WF, Nguyen VH, Cuong NM, Soejarto DD, Fong HHS, Rong L. Correction to Potent Inhibitor of Drug-Resistant HIV-1 Strains Identified from the Medicinal Plant Justicia gendarussa. Journal of Natural Products. PMID 28727428 DOI: 10.1021/Acs.Jnatprod.7B00562 |
0.763 |
|
| 2017 |
Cheng H, Schafer A, Soloveva V, Gharaibeh D, Kenny T, Retterer C, Zamani R, Bavari S, Peet NP, Rong L. Identification of a coumarin-based antihistamine as an anti-filoviral entry inhibitor. Antiviral Research. PMID 28645623 DOI: 10.1016/J.Antiviral.2017.06.015 |
0.494 |
|
| 2017 |
Zhang HJ, Rumschlag-Booms E, Guan YF, Wang DY, Liu KL, Li WF, Nguyen VH, Cuong NM, Soejarto DD, Fong HHS, Rong L. Potent Inhibitor of Drug-Resistant HIV-1 Strains Identified from the Medicinal Plant Justicia gendarussa. Journal of Natural Products. PMID 28613071 DOI: 10.1021/Acs.Jnatprod.7B00004 |
0.768 |
|
| 2017 |
Basu A, Komazin-Meredith G, McCarthy C, Antanasijevic A, Cardinale SC, Mishra RK, Barnard DL, Caffrey M, Rong L, Bowlin TL. Molecular Mechanism Underlying the Action of the Influenza A Virus Fusion Inhibitor MBX2546. Acs Infectious Diseases. PMID 28301927 DOI: 10.1021/Acsinfecdis.6B00194 |
0.487 |
|
| 2017 |
Zhang HJ, Rumschlag-Booms E, Guan YF, Liu KL, Wang DY, Li WF, Nguyen VH, Cuong NM, Soejarto DD, Fong HH, Rong L. Anti-HIV diphyllin glycosides from Justicia gendarussa. Phytochemistry. PMID 28110956 DOI: 10.1016/J.Phytochem.2017.01.005 |
0.763 |
|
| 2016 |
Antanasijevic A, Hafeman NJ, Tundup S, Kingsley C, Mishra RK, Rong L, Manicassamy B, Wardrop D, Caffrey M. Stabilization and Improvement of a Promising Influenza Antiviral: Making a PAIN PAINless. Acs Infectious Diseases. 2: 608-615. PMID 27759373 DOI: 10.1021/Acsinfecdis.6B00046 |
0.698 |
|
| 2016 |
Zhang Z, Yang E, Hu C, Cheng H, Chen CY, Huang D, Wang R, Zhao Y, Rong L, Vignuzzi M, Shen H, Shen L, Chen ZW. Cell-based high-throughput screening assay identifies 2', 2'-difluoro-2'-deoxycytidine Gemcitabine as potential anti-poliovirus agent. Acs Infectious Diseases. PMID 27733043 DOI: 10.1021/Acsinfecdis.6B00116 |
0.354 |
|
| 2016 |
Yang Y, Cheng H, Yan H, Wang PZ, Rong R, Zhang YY, Zhang CB, Du RK, Rong LJ. A cell-based high-throughput protocol to screen entry inhibitors of highly pathogenic viruses with Traditional Chinese Medicines. Journal of Medical Virology. PMID 27704591 DOI: 10.1002/jmv.24705 |
0.374 |
|
| 2016 |
Wang J, Liu Q, Rong L, Yang H, Jiao F, Chen X. Enantioselective extraction of phenylsuccinic acid in aqueous two-phase systems based on acetone and β-cyclodextrin derivative: Modeling and optimization through response surface methodology. Journal of Chromatography. A. PMID 27372416 DOI: 10.1016/J.Chroma.2016.06.054 |
0.422 |
|
| 2016 |
Shu T, Wu T, Pang M, Liu C, Wang X, Wang J, Liu B, Rong L. Effects and mechanisms of melatonin on neural differentiation of induced pluripotent stem cells. Biochemical and Biophysical Research Communications. PMID 27130826 DOI: 10.1016/j.bbrc.2016.04.108 |
0.453 |
|
| 2016 |
Xu A, Liu Y, Chen W, Wang J, Xue Y, Huang F, Rong L, Lin J, Liu D, Yan M, Li QZ, Li B, Song J, Olsen N, Zheng SG. TGF-β-Induced Regulatory T Cells Directly Suppress B Cell Responses through a Noncytotoxic Mechanism. Journal of Immunology (Baltimore, Md. : 1950). PMID 27001954 DOI: 10.4049/Jimmunol.1501740 |
0.452 |
|
| 2016 |
Antanasijevic A, Kingsley C, Basu A, Bowlin TL, Rong L, Caffrey M. Application of virus-like particles (VLP) to NMR characterization of viral membrane protein interactions. Journal of Biomolecular Nmr. PMID 26921030 DOI: 10.1007/S10858-016-0025-1 |
0.432 |
|
| 2016 |
Ichiyama K, Yang C, Chandrasekaran L, Liu S, Rong L, Zhao Y, Gao S, Lee A, Ohba K, Suzuki Y, Yoshinaka Y, Shimotohno K, Miyakawa K, Ryo A, Hedrick J, et al. Cooperative Orthogonal Macromolecular Assemblies with Broad Spectrum Antiviral Activity, High Selectivity, and Resistance Mitigation Macromolecules. 49: 2618-2629. DOI: 10.1021/acs.macromol.6b00091 |
0.371 |
|
| 2015 |
Li WF, Wang J, Zhang JJ, Song X, Ku CF, Zou J, Li JX, Rong LJ, Pan LT, Zhang HJ. Henrin A: A New Anti-HIV Ent-Kaurane Diterpene from Pteris henryi. International Journal of Molecular Sciences. 16: 27978-27987. PMID 26610490 DOI: 10.3390/ijms161126071 |
0.475 |
|
| 2015 |
Cheng H, Koning K, O'Hearn A, Wang M, Rumschlag-Booms E, Varhegyi E, Rong L. A parallel genome-wide RNAi screening strategy to identify host proteins important for entry of Marburg virus and H5N1 influenza virus. Virology Journal. 12: 194. PMID 26596270 DOI: 10.1186/S12985-015-0420-3 |
0.814 |
|
| 2015 |
Basu A, Mills DM, Mitchell D, Ndungo E, Williams JD, Herbert AS, Dye JM, Moir DT, Chandran K, Patterson JL, Rong L, Bowlin TL. Novel Small Molecule Entry Inhibitors of Ebola Virus. The Journal of Infectious Diseases. 212: S425-34. PMID 26206510 DOI: 10.1093/Infdis/Jiv223 |
0.506 |
|
| 2015 |
Cheng H, Lear-Rooney CM, Johansen L, Varhegyi E, Chen ZW, Olinger GG, Rong L. Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists. Journal of Virology. 89: 9932-8. PMID 26202243 DOI: 10.1128/Jvi.01337-15 |
0.451 |
|
| 2015 |
Shu T, Pang M, Rong L, Liu C, Wang J, Zhou W, Wang X, Liu B. Protective Effects and Mechanisms of Salvianolic Acid B Against H2O 2-Induced Injury in Induced Pluripotent Stem Cell-Derived Neural Stem Cells. Neurochemical Research. 40: 1133-43. PMID 25855584 DOI: 10.1007/s11064-015-1573-6 |
0.451 |
|
| 2015 |
O'Hearn A, Wang M, Cheng H, Lear-Rooney CM, Koning K, Rumschlag-Booms E, Varhegyi E, Olinger G, Rong L. Role of EXT1 and Glycosaminoglycans in the Early Stage of Filovirus Entry. Journal of Virology. 89: 5441-9. PMID 25741008 DOI: 10.1128/Jvi.03689-14 |
0.818 |
|
| 2014 |
Wang J, Gao Y, Wang QS, Zhang Y, Rong L, Wang J. [Research on cleaning rate of the C-shaped canal treated by manual or rotary endodontic file combined with ultrasonic rinsing]. Shanghai Kou Qiang Yi Xue = Shanghai Journal of Stomatology. 23: 441-5. PMID 25338795 |
0.411 |
|
| 2014 |
Han J, Rong LF, Shi CB, Dong XG, Wang J, Wang BL, Wen H, He ZY. Screening of lymph nodes metastasis associated lncRNAs in colorectal cancer patients. World Journal of Gastroenterology. 20: 8139-50. PMID 25009386 DOI: 10.3748/wjg.v20.i25.8139 |
0.422 |
|
| 2014 |
Antanasijevic A, Basu A, Bowlin TL, Mishra RK, Rong L, Caffrey M. Mutagenesis studies of the H5 influenza hemagglutinin stem loop region. The Journal of Biological Chemistry. 289: 22237-45. PMID 24947513 DOI: 10.1074/Jbc.M114.572974 |
0.465 |
|
| 2014 |
Shu T, Pang M, Rong L, Zhou W, Wang J, Liu C, Wang X. Effects of Salvia miltiorrhiza on neural differentiation of induced pluripotent stem cells. Journal of Ethnopharmacology. 153: 233-41. PMID 24568774 DOI: 10.1016/j.jep.2014.02.028 |
0.429 |
|
| 2014 |
Basu A, Antanasijevic A, Wang M, Li B, Mills DM, Ames JA, Nash PJ, Williams JD, Peet NP, Moir DT, Prichard MN, Keith KA, Barnard DL, Caffrey M, Rong L, et al. New small molecule entry inhibitors targeting hemagglutinin-mediated influenza a virus fusion. Journal of Virology. 88: 1447-60. PMID 24198411 DOI: 10.1128/Jvi.01225-13 |
0.52 |
|
| 2014 |
Wang J, Cheng H, Ratia K, Varhegyi E, Hendrickson WG, Li J, Rong L. A comparative high-throughput screening protocol to identify entry inhibitors of enveloped viruses. Journal of Biomolecular Screening. 19: 100-7. PMID 23821643 DOI: 10.1177/1087057113494405 |
0.679 |
|
| 2013 |
Antanasijevic A, Cheng H, Wardrop DJ, Rong L, Caffrey M. Inhibition of influenza H7 hemagglutinin-mediated entry. Plos One. 8: e76363. PMID 24194835 DOI: 10.1371/Journal.Pone.0076363 |
0.385 |
|
| 2013 |
Shu T, Chen GH, Rong L, Feng F, Yang B, Chen R, Wang J. Indirect comparison of anti-TNF-α agents for active ankylosing spondylitis: mixed treatment comparison of randomized controlled trials. Clinical and Experimental Rheumatology. 31: 717-22. PMID 23899710 |
0.425 |
|
| 2013 |
Tisoncik-Go J, Cordero KS, Rong L. Analysis of oseltamivir resistance substitutions in influenza virus glycoprotein neuraminidase using a lentivirus-based surrogate assay system. Virologica Sinica. 28: 81-91. PMID 23385316 DOI: 10.1007/S12250-013-3307-8 |
0.467 |
|
| 2013 |
Rumschlag-Booms E, Rong L. Influenza a virus entry: implications in virulence and future therapeutics. Advances in Virology. 2013: 121924. PMID 23365574 DOI: 10.1155/2013/121924 |
0.819 |
|
| 2013 |
Arslan AD, He X, Wang M, Rumschlag-Booms E, Rong L, Beck WT. A high-throughput assay to identify small-molecule modulators of alternative pre-mRNA splicing. Journal of Biomolecular Screening. 18: 180-90. PMID 22972848 DOI: 10.1177/1087057112459901 |
0.77 |
|
| 2012 |
McCullough C, Wang M, Rong L, Caffrey M. Characterization of influenza hemagglutinin interactions with receptor by NMR. Plos One. 7: e33958. PMID 22815674 DOI: 10.1371/Journal.Pone.0033958 |
0.376 |
|
| 2012 |
Huynh GT, Rong L. Modeling the dynamics of virus shedding into the saliva of Epstein-Barr virus positive individuals. Journal of Theoretical Biology. 310: 105-14. PMID 22683365 DOI: 10.1016/J.Jtbi.2012.05.032 |
0.339 |
|
| 2012 |
Wang M, Tscherne DM, McCullough C, Caffrey M, García-Sastre A, Rong L. Residue Y161 of influenza virus hemagglutinin is involved in viral recognition of sialylated complexes from different hosts. Journal of Virology. 86: 4455-62. PMID 22301136 DOI: 10.1128/Jvi.07187-11 |
0.5 |
|
| 2011 |
Rumschlag-Booms E, Zhang H, Soejarto DD, Fong HH, Rong L. Development of an Antiviral Screening Protocol: One-Stone-Two-Birds. Journal of Antivirals & Antiretrovirals. 3: 8-10. PMID 22140608 DOI: 10.4172/Jaa.1000027 |
0.818 |
|
| 2011 |
Wang JH, Pianko MJ, Ke X, Herskovic A, Hershow R, Cotler SJ, Chen W, Chen ZW, Rong L. Characterization of antigenic variants of hepatitis C virus in immune evasion. Virology Journal. 8: 377. PMID 21801418 DOI: 10.1186/1743-422X-8-377 |
0.542 |
|
| 2011 |
Wang J, Manicassamy B, Caffrey M, Rong L. Characterization of the receptor-binding domain of Ebola glycoprotein in viral entry. Virologica Sinica. 26: 156-70. PMID 21667336 DOI: 10.1007/S12250-011-3194-9 |
0.79 |
|
| 2011 |
Celigoy J, Ramirez B, Tao L, Rong L, Yan L, Feng YR, Quinnan GV, Broder CC, Caffrey M. Probing the HIV gp120 envelope glycoprotein conformation by NMR. The Journal of Biological Chemistry. 286: 23975-81. PMID 21592971 DOI: 10.1074/Jbc.M111.251025 |
0.375 |
|
| 2011 |
Basu A, Li B, Mills DM, Panchal RG, Cardinale SC, Butler MM, Peet NP, Majgier-Baranowska H, Williams JD, Patel I, Moir DT, Bavari S, Ray R, Farzan MR, Rong L, et al. Identification of a small-molecule entry inhibitor for filoviruses. Journal of Virology. 85: 3106-19. PMID 21270170 DOI: 10.1128/Jvi.01456-10 |
0.469 |
|
| 2011 |
Tisoncik JR, Guo Y, Cordero KS, Yu J, Wang J, Cao Y, Rong L. Identification of critical residues of influenza neuraminidase in viral particle release. Virology Journal. 8: 14. PMID 21232128 DOI: 10.1186/1743-422X-8-14 |
0.786 |
|
| 2011 |
Yermolina MV, Wang J, Caffrey M, Rong LL, Wardrop DJ. Discovery, synthesis, and biological evaluation of a novel group of selective inhibitors of filoviral entry. Journal of Medicinal Chemistry. 54: 765-81. PMID 21204524 DOI: 10.1021/Jm1008715 |
0.57 |
|
| 2011 |
Arslan AD, He X, Wang M, Rumschlag-Booms E, Rong L, Beck WT. Abstract A180: Development of a high-throughput screening (HTS) assay to detect splicing inhibitors. Molecular Cancer Therapeutics. 10. DOI: 10.1158/1535-7163.Targ-11-A180 |
0.769 |
|
| 2010 |
Sen J, Yan T, Wang J, Rong L, Tao L, Caffrey M. Alanine scanning mutagenesis of HIV-1 gp41 heptad repeat 1: insight into the gp120-gp41 interaction. Biochemistry. 49: 5057-65. PMID 20481578 DOI: 10.1021/Bi1005267 |
0.58 |
|
| 2010 |
Martinez O, Johnson J, Manicassamy B, Rong L, Olinger GG, Hensley LE, Basler CF. Zaire Ebola virus entry into human dendritic cells is insensitive to cathepsin L inhibition. Cellular Microbiology. 12: 148-57. PMID 19775255 DOI: 10.1111/J.1462-5822.2009.01385.X |
0.67 |
|
| 2009 |
Jiang H, Wang J, Manicassamy B, Manicassamy S, Caffrey M, Rong L. The Role of the Charged Residues of the GP2 Helical Regions in Ebola Entry(). Virologica Sinica. 24: 121-135. PMID 23227032 DOI: 10.1007/S12250-009-3015-6 |
0.786 |
|
| 2009 |
Zhang H, Rothwangl K, Mesecar AD, Sabahi A, Rong L, Fong HH. Lamiridosins, hepatitis C virus entry inhibitors from Lamium album. Journal of Natural Products. 72: 2158-62. PMID 19904996 DOI: 10.1021/Np900549E |
0.332 |
|
| 2009 |
Guo Y, Tisoncik J, McReynolds S, Farzan M, Prabhakar BS, Gallagher T, Rong L, Caffrey M. Identification of a new region of SARS-CoV S protein critical for viral entry. Journal of Molecular Biology. 394: 600-5. PMID 19853613 DOI: 10.1016/J.Jmb.2009.10.032 |
0.799 |
|
| 2009 |
McReynolds S, Jiang S, Rong L, Caffrey M. Dynamics of SARS-coronavirus HR2 domain in the prefusion and transition states. Journal of Magnetic Resonance (San Diego, Calif. : 1997). 201: 218-21. PMID 19819173 DOI: 10.1016/J.Jmr.2009.09.012 |
0.357 |
|
| 2009 |
Rumschlag-Booms E, Guo Y, Wang J, Caffrey M, Rong L. Comparative analysis between a low pathogenic and a high pathogenic influenza H5 hemagglutinin in cell entry. Virology Journal. 6: 76. PMID 19515258 DOI: 10.1186/1743-422X-6-76 |
0.811 |
|
| 2009 |
Manicassamy B, Rong L. Expression of Ebolavirus glycoprotein on the target cells enhances viral entry. Virology Journal. 6: 75. PMID 19505320 DOI: 10.1186/1743-422X-6-75 |
0.714 |
|
| 2009 |
Wang JH, Zheng X, Ke X, Dorak MT, Shen J, Boodram B, O'Gorman M, Beaman K, Cotler SJ, Hershow R, Rong L. Ethnic and geographical differences in HLA associations with the outcome of hepatitis C virus infection. Virology Journal. 6: 46. PMID 19409091 DOI: 10.1186/1743-422X-6-46 |
0.519 |
|
| 2009 |
Guo Y, Rumschlag-Booms E, Wang J, Xiao H, Yu J, Wang J, Guo L, Gao GF, Cao Y, Caffrey M, Rong L. Analysis of hemagglutinin-mediated entry tropism of H5N1 avian influenza. Virology Journal. 6: 39. PMID 19341465 DOI: 10.1186/1743-422X-6-39 |
0.812 |
|
| 2009 |
Rothwangl KB, Rong L. Analysis of a conserved RGE/RGD motif in HCV E2 in mediating entry. Virology Journal. 6: 12. PMID 19171049 DOI: 10.1186/1743-422X-6-12 |
0.304 |
|
| 2009 |
Liu HL, Rong LJ, Zhou B, Wei JC, Zheng QS, Chen PY. [Characterization of murine leukemia virus recombinants that express H5N1 subtype avian influenza virus hemagglutinin glycoproteins]. Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology. 21: 47-51. PMID 15859328 |
0.366 |
|
| 2008 |
Xiong GX, Zhan JM, Jiang HY, Li JF, Rong LW, Xu G, Xu G. Computational fluid dynamics simulation of airflow in the normal nasal cavity and paranasal sinuses. American Journal of Rhinology. 22: 477-82. PMID 18954506 DOI: 10.2500/ajr.2008.22.3211 |
0.414 |
|
| 2008 |
Wang J, Sen J, Rong L, Caffrey M. Role of the HIV gp120 conserved domain 1 in processing and viral entry. The Journal of Biological Chemistry. 283: 32644-9. PMID 18815131 DOI: 10.1074/Jbc.M806099200 |
0.589 |
|
| 2008 |
McReynolds S, Jiang S, Guo Y, Celigoy J, Schar C, Rong L, Caffrey M. Characterization of the prefusion and transition states of severe acute respiratory syndrome coronavirus S2-HR2. Biochemistry. 47: 6802-8. PMID 18540634 DOI: 10.1021/Bi800622T |
0.348 |
|
| 2008 |
Rothwangl KB, Manicassamy B, Uprichard SL, Rong L. Dissecting the role of putative CD81 binding regions of E2 in mediating HCV entry: putative CD81 binding region 1 is not involved in CD81 binding. Virology Journal. 5: 46. PMID 18355410 DOI: 10.1186/1743-422X-5-46 |
0.645 |
|
| 2007 |
Sen J, Jacobs A, Jiang H, Rong L, Caffrey M. The disulfide loop of gp41 is critical to the furin recognition site of HIV gp160. Protein Science : a Publication of the Protein Society. 16: 1236-41. PMID 17525470 DOI: 10.1110/Ps.072771407 |
0.577 |
|
| 2007 |
Manicassamy B, Wang J, Rumschlag E, Tymen S, Volchkova V, Volchkov V, Rong L. Characterization of Marburg virus glycoprotein in viral entry. Virology. 358: 79-88. PMID 16989883 DOI: 10.1016/J.Virol.2006.06.041 |
0.796 |
|
| 2006 |
Hakansson-McReynolds S, Jiang S, Rong L, Caffrey M. Solution structure of the severe acute respiratory syndrome-coronavirus heptad repeat 2 domain in the prefusion state. The Journal of Biological Chemistry. 281: 11965-71. PMID 16507566 DOI: 10.1074/Jbc.M601174200 |
0.36 |
|
| 2005 |
Rai T, Caffrey M, Rong L. Identification of two residues within the LDL-A module of Tva that dictate the altered receptor specificity of mutant subgroup A avian sarcoma and leukosis viruses. Journal of Virology. 79: 14962-6. PMID 16282495 DOI: 10.1128/Jvi.79.23.14962-14966.2005 |
0.65 |
|
| 2005 |
Jacobs A, Sen J, Rong L, Caffrey M. Alanine scanning mutants of the HIV gp41 loop. The Journal of Biological Chemistry. 280: 27284-8. PMID 15917239 DOI: 10.1074/Jbc.M414411200 |
0.406 |
|
| 2005 |
Zhou YM, Yang RQ, Tao SC, Li Z, Zhang Q, Gao HF, Zhang ZW, Du JY, Zhu PX, Ren LL, Zhang L, Wang D, Guo L, Wang YB, Guo Y, ... ... Rong L, et al. The design and application of DNA chips for early detection of SARS-CoV from clinical samples. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 33: 123-31. PMID 15911427 DOI: 10.1016/J.Jcv.2004.10.019 |
0.49 |
|
| 2005 |
Manicassamy B, Wang J, Jiang H, Rong L. Comprehensive analysis of ebola virus GP1 in viral entry. Journal of Virology. 79: 4793-805. PMID 15795265 DOI: 10.1128/Jvi.79.8.4793-4805.2005 |
0.815 |
|
| 2004 |
Guo Y, Yu X, Rihani K, Wang QY, Rong L. The role of a conserved acidic residue in calcium-dependent protein folding for a low density lipoprotein (LDL)-A module: implications in structure and function for the LDL receptor superfamily. The Journal of Biological Chemistry. 279: 16629-37. PMID 14749324 DOI: 10.1074/Jbc.M400157200 |
0.533 |
|
| 2004 |
Rai T, Marble D, Rihani K, Rong L. The spacing between cysteines two and three of the LDL-A module of Tva is important for subgroup A avian sarcoma and leukosis virus entry. Journal of Virology. 78: 683-91. PMID 14694099 DOI: 10.1128/Jvi.78.2.683-691.2004 |
0.611 |
|
| 2003 |
Yu X, Wang QY, Guo Y, Dolmer K, Young JA, Gettins PG, Rong L. Kinetic analysis of binding interaction between the subgroup A Rous sarcoma virus glycoprotein SU and its cognate receptor Tva: calcium is not required for ligand binding. Journal of Virology. 77: 7517-26. PMID 12805452 DOI: 10.1128/Jvi.77.13.7517-7526.2003 |
0.615 |
|
| 2002 |
Wang QY, Manicassamy B, Yu X, Dolmer K, Gettins PG, Rong L. Characterization of the LDL-A module mutants of Tva, the subgroup A Rous sarcoma virus receptor, and the implications in protein folding. Protein Science : a Publication of the Protein Society. 11: 2596-605. PMID 12381843 DOI: 10.1110/Ps.0219802 |
0.741 |
|
| 2002 |
Wang QY, Huang W, Dolmer K, Gettins PG, Rong L. Solution structure of the viral receptor domain of Tva and its implications in viral entry. Journal of Virology. 76: 2848-56. PMID 11861852 DOI: 10.1128/Jvi.76.6.2848-2856.2002 |
0.606 |
|
| 2001 |
Wang QY, Dolmer K, Huang W, Gettins PG, Rong L. Role of calcium in protein folding and function of Tva, the receptor of subgroup A avian sarcoma and leukosis virus. Journal of Virology. 75: 2051-8. PMID 11160709 DOI: 10.1128/Jvi.75.5.2051-2058.2001 |
0.567 |
|
| 1999 |
Damico R, Rong L, Bates P. Substitutions in the Receptor-Binding Domain of the Avian Sarcoma and Leukosis Virus Envelope Uncouple Receptor-Triggered Structural Rearrangements in the Surface and Transmembrane Subunits Journal of Virology. 73: 3087-3094. DOI: 10.1128/Jvi.73.4.3087-3094.1999 |
0.59 |
|
| 1998 |
Rong L, Gendron K, Bates P. Conversion of a human low-density lipoprotein receptor ligand-binding repeat to a virus receptor: Identification of residues important for ligand specificity Proceedings of the National Academy of Sciences of the United States of America. 95: 8467-8472. PMID 9671701 DOI: 10.1073/Pnas.95.15.8467 |
0.606 |
|
| 1998 |
Bates P, Rong L, Varmus HE, Young JA, Crittenden LB. Genetic mapping of the cloned subgroup A avian sarcoma and leukosis virus receptor gene to the TVA locus. Journal of Virology. 72: 2505-8. PMID 9499114 DOI: 10.1128/Jvi.72.3.2505-2508.1998 |
0.664 |
|
| 1998 |
Rong L, Gendron K, Strohl B, Shenoy R, Wool-Lewis RJ, Bates P. Characterization of Determinants for Envelope Binding and Infection in Tva, the Subgroup A Avian Sarcoma and Leukosis Virus Receptor Journal of Virology. 72: 4552-4559. DOI: 10.1128/jvi.72.6.4552-4559.1998 |
0.353 |
|
| 1997 |
Rong L, Edinger A, Bates P. Role of basic residues in the subgroup-determining region of the subgroup A avian sarcoma and leukosis virus envelope in receptor binding and infection. Journal of Virology. 71: 3458-3465. DOI: 10.1128/Jvi.71.5.3458-3465.1997 |
0.607 |
|
| 1995 |
Rong L, Bates P. Analysis of the subgroup A avian sarcoma and leukosis virus receptor: The 40-residue, cysteine-rich, low-density lipoprotein receptor repeat motif of tva is sufficient to mediate viral entry Journal of Virology. 69: 4847-4853. PMID 7609052 DOI: 10.1128/Jvi.69.8.4847-4853.1995 |
0.639 |
|
| Show low-probability matches. |